Greater Glasgow and Clyde Medicines

An encouraging downward trend in use (by volume and cost) is noted for the high cost liquid medicines previously highlighted in a

To aid medicines reconciliation/supply for care home patients in acute care

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formular

Launch of the two new “triple inhalers” described below has presented an opportunity to simplify inhaler regimens for some patients with COPD, while simultaneously generating substantial efficiency savings. Note that Trimbow...

GP Practices and Community Pharmacies can now order printed copies of the new Direct Oral Anticoagulant (DOAC) Patient Information Booklet and Alert Card. Printed copies remain available for use in hospitals across NHSGGC. Please refer to this ...

Updated Adult NHSGGC Guidelines now available on Staffnet         Sign Guidelines     <...

Drug Safety Update (October 2018) includes: Rivaroxaban (Xarelto▼)

Yellow Card Scotland has provided a summary of the importance and relevance to practice of reporting adverse drug reactions (ADRs) via the Yellow Card scheme. KEY POINTS As little as 2 or 3 reports of an ...

The Adult Therapeutics Handbook content has now been updated and includes the following main changes: Respiratory System The

A Direct Oral Anticoagulant (DOAC) Patient Information Booklet and Alert Card have been developed for use across NHSGGC. This new resource is suitable for patients taking apixaban, dabigatran, edoxaban or rivaroxaban and highlights key ...